Evidence map›Paper›PMID 19073653›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2009

Splice variants of neuronal nitric oxide synthase are present in the rat kidney.

Cheryl Smith, Michael Merchant, Andrea Fekete, Ha-Long Nyugen, Paul Oh, You-Lin Tain, Jon B Klein, Chris Baylis

Open access · bronzeAbstract read
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury.Journal of the American Society of Nephrology : JASN · 2017
    Article
  5. Macula Densa Nitric Oxide Synthase 1β Protects against Salt-Sensitive Hypertension.Journal of the American Society of Nephrology : JASN · 2016
    Article
  6. Article
  7. Dynamin-2 is a novel NOS1β interacting protein and negative regulator in the collecting duct.American journal of physiology. Regulatory, integrative and comparative physiology · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Nitric oxide and the A and B of endothelin of sodium homeostasis.Current opinion in nephrology and hypertension · 2013
    Review
  14. Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.The journals of gerontology. Series A, Biological sciences and medical sciences · 2012
    Review
  15. Article
  16. Article
  17. Article
  18. Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2012
    Article
  19. Nitric oxide synthase derangements and hypertension in kidney disease.Current opinion in nephrology and hypertension · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Cheryl SmithDepartment of Physiology and Functional Genomics, University of Florida, POB 100274, Gainesville, FL 36210, USA.
Michael Merchant
Andrea Fekete
Ha-Long Nyugen
Paul Oh
You-Lin Tain
Jon B Klein
Chris Baylis
University of Florida · USUniversity of Louisville · US

Funding

Nitrix Oxide in Chronic Renal DiseaseR01DK056843 · NIDDK · WEST VIRGINIA UNIVERSITY · PI BAYLIS, CHRISTINE · 2001 to 2015
$3.4M
NIDDK NIH HHS R01 DK056843NIDDK NIH HHS R01DK056843
6 · The paper itself

Abstract

backgroundDecreased renal cortical neuronal NO synthase (nNOS) abundance/activity correlates with progression of chronic kidney disease (CKD) in a number of animal models.

methodsWestern blotting with both N-terminal and C-terminal antibodies, immunoprecipitation, proteomics, RT-PCR and in situ hybridization were used to identify nNOS splice variants in the rat kidney.

resultsWe have identified two nNOS proteins and transcripts in the rat kidney; nNOSalpha (approximately 160 kDa) and nNOSbeta (approximately 140 kDa), a catalytically active exon-2 deletion variant, lacking both the PDZ and protein inhibitor of nNOS (PIN) domains. We also report that nNOSbeta protein abundance is increased in the kidney at 11 weeks following 5/6th nephrectomy (5/6NX)-induced CKD while nNOSalpha protein abundance is diminished. The transcript data parallel the protein data in 5/6NX. By in situ hybridization, there is abundant nNOSalpha mRNA widely distributed throughout the normal kidney cortex, with very sparse nNOSbeta mRNA confined to a few proximal tubules. In a second injury model (6 weeks after 5/6 renal mass reduction by combined right kidney ablation and infarction of approximately 2/3 of the left kidney; 5/6 A/I), nNOSalpha mRNA almost disappears from the kidney cortex while nNOSbeta mRNA abundance increases in tubules and tubulo-interstitium.

conclusionThe renal cortical nNOSbeta protein is present in low abundance in the normal kidney and increases with injury, in an inverse pattern of change with the nNOSalpha.

Indexed as

AnimalsChronic DiseaseDisease Models, AnimalFemaleGenetic VariationIsoenzymesKidney CortexKidney DiseasesMaleNephrectomyNitric Oxide Synthase Type IProtein IsoformsRatsRNA, MessengerIsoenzymesNitric Oxide Synthase Type IProtein IsoformsRNA, Messenger

Identifiers

PMID19073653
PMCPMC2721461
OpenAlexW2159007443

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.